I. Adalet et al., Determination of medullary thyroid carcinoma metastases by Tl-201, Tc-99(m)(V)DMSA, Tc-99(m)-MIBI and Tc-99(m)-tetrofosmin, NUCL MED C, 20(4), 1999, pp. 353-359
Medullary carcinoma of the thyroid (MCT) is malignancy derived from the par
afollicular cells (or C-cells) of the thyroid. It is usually sporadic, alth
ough it is familial in some cases. Several scintigraphic procedures can pro
vide information regarding the primary and metastatic foci of the tumour. W
e performed whole-body scanning to establish the pathology of MCT using Tl-
201, Tc-99(m)(V)DMSA and Tc-99(m)-MIBI in 14 patients, and found average se
nsitivities of 73%, 82% and 81%, respectively. Moreover, we also scanned th
ree patients with Tc-99(m)-tetrofosmin and identified two of four pathologi
cal foci as well as residual thyroid tissue. The sensitivities of Tl-201, T
c-99(m)(V)DMSA and Tc-99(m)-MIBI were 100%, 100% and 85% in identifying lym
phadenopathies; 40%, 50% and 71% for soft tissue foci; 100%, 100% and 100%
for foci in pulmonary parenchyma; and 100%, 66% and 100% for recurrences in
thyroid gland. Although Tc-99(m)(V)DMSA identified all bony metastases in
three patients (100%), Tc-99(m)-MIBI detected only two of three foci (66%)
and Tl-201 none. Tl-201, Tc-99(m)-MIB and Tc-99(m)-tetrofosmin accumulated
in residual thyroid tissue, but Tc-99(m)(V)DMSA did not, as expected. We co
nclude that these agents were complementary, since they had different sensi
tivities in different tissues. The tumour-seeking properties of tetrofosmin
are to be evaluated in a larger series. ((C) 1999 Lippincott Williams & Wi
lkins).